Tetrabenazine

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Nitoman (aaiPharma); Xenazine (Alliance)
  • INDICATIONS: Hyperkinetic movement disorders: Huntington's chorea, hemiballismus, senile chorea, Tourette syndrome, and tardive dyskinesia
  • CLASS: Vesicular monoamine transporter 2 inhibitor
  • HALF-LIFE: 2–8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Amantadine, Amiodarone, Amitriptyline, Amoxapine, Antiarrhythmics, Antibiotics, Antipsychotics, Arsenic, Chlorpromazine, Cinacalcet, Citalopram, Cyclic antidepressants, Dasatinib, Degarelix, Delavirdine, Deutetrabenazine, Dolasetron, Haloperidol, Lapatinib, Levodopa, Levofloxacin, Levomepromazine, Linezolid, Lithium, Lurasidone, MAO inhibitors, Metoclopramide, Moxifloxacin, Olanzapine, Paliperidone, Paroxetine Hydrochloride, Pazopanib, Procainamide, QT prolonging drugs, Quinidine, Reserpine, Risperidone, Sotalol, Telavancin, Telithromycin, Terbinafine, Thioridazine, Tipranavir, Voriconazole, Vorinostat, Ziprasidone, Zuclopenthixol

PREGNANCY CATEGORY: N/A
Based on animal data, may cause fetal harm

DEPRESSION AND SUICIDALITY

See full prescribing information for complete boxed warning.

Our database has 49 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
NEUROMUSCULAR/SKELETAL
OCULAR
RESPIRATORY


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top